SHUBHAM PANT to Cetuximab
This is a "connection" page, showing publications SHUBHAM PANT has written about Cetuximab.
Connection Strength
0.128
-
Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab. J Oncol Pharm Pract. 2015 Jun; 21(3):232-7.
Score: 0.104
-
Cetuximab hypersensitivity infusion reactions: Incidence and risk factors. J Oncol Pharm Pract. 2013 Sep; 19(3):222-7.
Score: 0.024